Business Context and Reporting Period
This Form 8-K Current Report was filed by Globus Medical, Inc. on April 23, 2015. The filing reports a material corporate governance event regarding the appointment of a new senior executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Daniel T. Scavilla as Senior Vice President and Chief Financial Officer, effective May 4, 2015.
- Background: Mr. Scavilla brings 28 years of experience from Johnson & Johnson (J&J).
- Recent Roles: He served as CFO and Global Vice President of Finance & Business Operations for J&J Vision Care (2012–2015) and previously as CFO and Worldwide Vice President of Finance for Advanced Sterilization Products (2007–2012).
- Education: B.S. from LaSalle University and M.B.A. from Temple University.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook statements, management commentary on market conditions, or specific risk factors. The document serves solely to disclose the executive appointment and includes a press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the effective start date of Daniel T. Scavilla as CFO (May 4, 2015).
- Review the attached press release (Exhibit 99.1) for additional details on the transition plan.
- Confirm the departure date of the previous CFO, if applicable, by cross-referencing prior filings.
- Assess the strategic impact of hiring a CFO with extensive medical device experience from a major competitor/partner (J&J).